Peak6 Investments LLC Axonics, Inc. Transaction History

Peak6 Investments LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$39.5 - $64.42 $139,869 - $228,111	-3,541 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$43.74 - $62.76 $345,983 - $496,431	-7,910 Reduced 69.08%	3,541 $222,000
Q4 2021 Feb 11, 2022	BUY	$50.01 - $73.35 $413,532 - $606,531	8,269 Added 259.87%	11,451 $641,000
Q2 2021 Aug 13, 2021	SELL	$51.39 - $66.9 $1.16 Million - $1.51 Million	-22,643 Reduced 87.68%	3,182 $202,000
Q4 2020 Feb 12, 2021	BUY	$42.19 - $51.5 $200,486 - $244,728	4,752 Added 22.55%	25,825 $1.29 Million
Q3 2020 Nov 13, 2020	BUY	$35.33 - $51.04 $320,266 - $462,677	9,065 Added 75.49%	21,073 $1.08 Million
Q2 2020 Aug 14, 2020	BUY	$22.91 - $39.83 $275,103 - $478,278	12,008 New	12,008 $422,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.